Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY
· Real-Time Price · USD
1.08
0.14 (14.86%)
At close: Aug 15, 2025, 3:59 PM
1.05
-2.79%
After-hours: Aug 15, 2025, 07:06 PM EDT
Oncolytics Biotech Income Statement
Financials in CAD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 123K | 230K | 333K | 429K | 403K | 395.01K | 389.83K | 391.44K | 392K | 389.96K | 376.67K | 442.89K | 452.06K | 355.09K | 270.57K | 106.73K |
Gross Profit | -98K | -221K | -328K | -431K | -429K | -403K | -395.01K | -389.83K | -391.44K | -392K | -389.96K | -376.67K | -442.89K | -452.06K | -355.09K | -270.57K | -106.73K |
Operating Income | -24.82M | -26.55M | -35.39M | -36.54M | -35.78M | -33.79M | -33.15M | -28.16M | -27.97M | -27.55M | -26.8M | -26.89M | -26.64M | -26.23M | -26.85M | -27.01M | -25.84M |
Interest Income | 876K | 1.2M | 1.54M | 1.58M | 1.51M | 1.33M | 1.15M | 991.75K | 773.75K | 526.75K | 235.16K | 114.89K | 95.12K | 98.61K | 85.84K | 73.47K | 76.78K |
Pretax Income | -31.37M | -31.58M | -27.49M | -27.88M | -28.11M | -27.66M | -32.25M | -26.73M | -24.41M | -24.75M | -23.96M | -24.42M | -26.6M | -26.25M | -27.87M | -29.76M | -29.34M |
Net Income | -31.5M | -31.71M | -27.64M | -28.02M | -28.21M | -27.42M | -32.03M | -26.51M | -24.16M | -25.77M | -24.97M | -25.43M | -27.58M | -26.3M | -27.88M | -29.76M | -29.34M |
Selling & General & Admin | 12.75M | 12.79M | 13.41M | 15.44M | 15.44M | 15.78M | 15.36M | 12.61M | 11.99M | 11.39M | 11.41M | 11.82M | 12.43M | 12.86M | 9.19M | 6.4M | 3.04M |
Research & Development | 19.99M | 21.65M | 21.75M | 20.77M | 19.91M | 17.71M | 17.89M | 15.76M | 15.26M | 15.43M | 14.27M | 13.87M | 13.87M | 12.92M | 13.3M | 13.88M | 13.17M |
Other Expenses | 521K | 424K | n/a | n/a | n/a | n/a | n/a | n/a | 2.84M | 5.44M | 9.22M | 12.1M | 12.77M | 13.31M | 13.55M | 13.14M | 12.66M |
Operating Expenses | 33.26M | 34.86M | 35.16M | 36.31M | 35.55M | 33.68M | 33.45M | 28.46M | 27.35M | 26.92M | 25.87M | 25.97M | 26.64M | 26.23M | 26.85M | 27.01M | 25.84M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.67M | 3.59M | 3.59M | 3.59M | -84.52K | n/a | n/a |
Cost & Expenses | 33.26M | 34.98M | 35.39M | 36.54M | 35.78M | 33.79M | 33.45M | 28.46M | 27.35M | 26.92M | 25.87M | 25.97M | 26.64M | 26.23M | 26.85M | 27.01M | 25.84M |
Income Tax Expense | 130K | 130K | 150K | 145K | 97K | -232K | -218.42K | -222.82K | -245K | 1.02M | 1.01M | 1.01M | 986.3K | 49.43K | 7.15K | n/a | n/a |
Shares Outstanding (Basic) | 84.63M | 76.09M | 77.02M | 76.09M | 75.24M | 73.73M | 69.8M | 64.47M | 62.34M | 59.51M | 58.33M | 57.67M | 56.58M | 54.96M | 54.96M | 54.33M | 49.67M |
Shares Outstanding (Diluted) | 84.63M | 76.09M | 77.02M | 76.09M | 75.24M | 73.73M | 69.8M | 64.47M | 62.34M | 59.51M | 58.33M | 57.67M | 56.58M | 54.96M | 54.96M | 54.33M | 49.67M |
EPS (Basic) | -0.41 | -0.42 | -0.36 | -0.38 | -0.41 | -0.41 | -0.5 | -0.43 | -0.4 | -0.44 | -0.44 | -0.46 | -0.5 | -0.49 | -0.57 | -0.64 | -0.68 |
EPS (Diluted) | -0.41 | -0.42 | -0.36 | -0.38 | -0.41 | -0.41 | -0.5 | -0.43 | -0.4 | -0.44 | -0.44 | -0.46 | -0.5 | -0.49 | -0.57 | -0.64 | -0.68 |
EBITDA | -32.95M | -34.66M | -35.06M | -36.21M | -35.35M | -33.39M | -33.13M | -28.15M | -27.11M | -26.68M | -25.55M | -25.66M | -26.29M | -25.87M | -26.48M | -26.61M | -25.4M |
EBIT | -33.26M | -34.98M | -35.39M | -36.54M | -35.78M | -33.79M | -33.45M | -28.46M | -27.35M | -26.92M | -25.87M | -25.97M | -26.64M | -26.23M | -26.85M | -27.01M | -25.84M |
Depreciation & Amortization | 300K | 326K | 335K | 333K | 429K | 403K | 395.01K | 389.83K | 391.44K | 392K | 389.96K | 376.67K | 442.89K | 452.06K | 462.72K | 487.97K | 438.85K |